BURNHAM INSTITUTE FOR MEDICAL RES has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are BIOGEN MA INC., PEPTECH LTD and TRILLIUM THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 10 | |
#2 | Brazil | 2 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Micro-structure and nano-technology |
# | Name | Total Patents |
---|---|---|
#1 | Liddington Robert C | 4 |
#2 | Pellecchia Maurizio | 4 |
#3 | Sui Jianhua | 4 |
#4 | Marasco Wayne A | 4 |
#5 | Ruoslahti Erkki | 3 |
#6 | Sugahara Kazuki | 2 |
#7 | Teesalu Tambet | 2 |
#8 | Reed John C | 2 |
#9 | Erkki Ruoslahti | 1 |
#10 | Sergienko Eduard | 1 |
Publication | Filing date | Title |
---|---|---|
AU2015201338A1 | Antibodies against influenza virus and methods of use thereof | |
AU2008338691A1 | Antibodies against influenza virus and methods of use thereof | |
AU2008311824A1 | Inhibitors of anti-apoptotic proteins | |
EP2205088A1 | Naphthalene-based inhibitors of anti-apoptotic proteins | |
AU2008229726A1 | Inhibitors of lethal factor protease |